Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer

Abstract

Our study indicates that nucleotyping is an independent prognostic factor in high-risk stage II colon cancer. Therefore, it may help subdivide patients into different subgroups and give them different strategies for follow-up and treatment in the future.